SCHEMBL5947696

SCHEMBL5947696

CN1C=CC(C2=c3ccc([nH]3)=C(C3=CCN(C)C=C3)C3=NC(Cl)(C=C3)C(Cl)(C3=CCN(C)C=C3)c3ccc([nH]3)C(c3ccccc3)=C3C=CC2=N3)=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7147334 0.99 — —
SCHEMBL7149929 0.99 — —
SCHEMBL7148663 0.95 — —
SCHEMBL8182556 0.92 — —
SCHEMBL8182744 0.91 — —
SCHEMBL8182068 0.91 — —
SCHEMBL8184161 0.89 — —
SCHEMBL8183373 0.84 — —
SCHEMBL7238996 0.79 — —
SCHEMBL9641187 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060258635-A1 Use of a porphyrin compound for the treatment of skin fungi PHOTOBIOCHEM N.V. (NL) 2006-11-16 — — US claimed
US-20040034006-A1 Method of inactivating viral particles in a blood product PHOTOBIOCHEM N.V. (NL) 2004-02-19 — — US claimed
US-20060258635-A1 Use of a porphyrin compound for the treatment of skin fungi PHOTOBIOCHEM N.V. (NL) 2006-11-16 — — US disclosed
US-20040034006-A1 Method of inactivating viral particles in a blood product PHOTOBIOCHEM N.V. (NL) 2004-02-19 — — US disclosed
US-20040014738-A1 Method of inactivating micro-organisms PHOTOBIOCHEM N. V. (NL) 2004-01-22 — — US disclosed
EP-1197147-A1 Method of inactivating viral particles in a blood product Boston Clinics PDT B.V. (NL) 2002-04-17 — — EP disclosed
EP-1197229-A1 Method of inactivating microorganisms Boston Clinics PDT B.V. (NL) 2002-04-17 — — EP disclosed
Send feedback